Talking about the latest research in cancer care, Dr. Victor Vogel will be joining Dr. Galati this week.
 
Dr. Vogel is Vice President of  National Research at the American Cancer Society. In this role, Dr. Vogel is responsible for overseeing the Society’s research operations. He will continue to build on the Society’s legacy of serving as the largest non-governmental funder of cancer research, with an emphasis on intramural research and extramural research funding to advance prevention, early detection and treatment of cancer. Dr. Vogel will actively collaborate with leading cancer research, academic institutions and government agencies to assure the organization’s access to current trends and developments in basic science and applied research. In addition, he will provide scientific expertise to the advocacy efforts of the American Cancer Society and other organizations working to improve support for cancer research and improved cancer care.

Dr. Vogel has more than 20 years of leadership in cancer research with his specific areas of interest being breast cancer risk assessment and prevention. He currently serves as professor of medicine and epidemiology at the University of Pittsburgh School of Medicine, where he is also co-director of the Magee-Womens Hospital/University of Pittsburgh Cancer Institute Biochemoprevention Program. A fellow of the American College of Preventive Medicine and a fellow of the American College of Physicians, Dr. Vogel is board-certified in internal medicine, medical oncology, and general preventive medicine/public health. He served as the National Protocol Chairman of the National Cancer Institute’s STAR Trial (Study of Tamoxifen and Raloxifene).

Dr. Vogel is the author of more than 250 articles, book chapters, and abstracts. He edited the books Management of Patients at High Risk for Breast Cancer and Handbook of Breast Cancer Risk Assessment: Evidence-Based Guidelines for Evaluation, Prevention, Counseling, and Treatment.